New York, NY · Founded 2018 · Privately Held (backing)
Operator of a fertility technology company intended to provide safety and transparency to modernize and transform egg and embryo storage. TMRW Life Sciences is based in New York, NY and was founded in 2018. It has raised $198 million across 5 recorded rounds; the latest was a $38.4 million early-stage round in Mar 2026.
Last price · $/share
—
Implied valuation
—
Total raised
$198.3M
Last round
Early Stage VC
Mar 2026
No prints on record
No secondary trades in TMRW Life Sciences shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TMRW Life Sciences with a free account
·The complete investor list: 17 names
·Watch TMRW Life Sciences: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of TMRW Life Sciences stock.
